FI973195L - Hajbroskextrakt, förfarande för framställning av desamma och deras användning - Google Patents

Hajbroskextrakt, förfarande för framställning av desamma och deras användning Download PDF

Info

Publication number: FI973195L
Authority: FI; Finland
Prior art keywords: preparation; hair extract; hair; extract
Prior art date: 1995-02-03

Application number

FI973195A

Other languages

English (en)

Finnish (fi)

Other versions

FI973195A0 (sv

FI117376B (sv

Inventor

Eric Dupont

Paul Brazeau

Christina Juneau

Daniel H Meas

Kenneth Marenus

Original Assignee

Aeterna Lab Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-03

Filing date

1997-08-01

Publication date

1997-10-01

1995-02-03 Priority claimed from US08/384,555 external-priority patent/US5618925A/en

1997-08-01 Application filed by Aeterna Lab Inc filed Critical Aeterna Lab Inc

1997-08-01 Publication of FI973195A0 publication Critical patent/FI973195A0/sv

1997-10-01 Publication of FI973195L publication Critical patent/FI973195L/sv

2006-09-29 Application granted granted Critical

2006-09-29 Publication of FI117376B publication Critical patent/FI117376B/sv

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Inorganic Chemistry (AREA)
Ophthalmology & Optometry (AREA)
Hematology (AREA)
Toxicology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Immunology (AREA)
Rheumatology (AREA)
Oncology (AREA)
Zoology (AREA)
Communicable Diseases (AREA)
Obesity (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Endocrinology (AREA)
Biochemistry (AREA)
Emergency Medicine (AREA)
Urology & Nephrology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Marine Sciences & Fisheries (AREA)
Gerontology & Geriatric Medicine (AREA)

FI973195A 1995-02-03 1997-08-01 Användning av hajbroskextrakter vid framställningen av medicin för att behandla en sjukdom som innefattar en kollagenolys- eller en inflammationsfaktor FI117376B (sv)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US08/384,555 US5618925A (en)	1994-04-28	1995-02-03	Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof
US38455595		1995-02-03
CA9500617		1995-10-30
PCT/CA1995/000617 WO1996023512A1 (en)	1995-02-03	1995-10-30	Extracts of shark cartilage, process of production and uses thereof

Publications (3)

Publication Number	Publication Date
FI973195A0 FI973195A0 (sv)	1997-08-01
FI973195L true FI973195L (sv)	1997-10-01
FI117376B FI117376B (sv)	2006-09-29

Family

ID=23517788

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI973195A FI117376B (sv)	1995-02-03	1997-08-01	Användning av hajbroskextrakter vid framställningen av medicin för att behandla en sjukdom som innefattar en kollagenolys- eller en inflammationsfaktor

Country Status (23)

Country	Link
EP (1)	EP0806960B1 (sv)
JP (3)	JPH11502514A (sv)
KR (1)	KR100347880B1 (sv)
CN (1)	CN1138550C (sv)
AT (1)	ATE230272T1 (sv)
AU (1)	AU717978B2 (sv)
BG (1)	BG63801B1 (sv)
BR (1)	BR9510540A (sv)
CA (1)	CA2212010C (sv)
CZ (1)	CZ292627B6 (sv)
DE (1)	DE69529300T2 (sv)
DK (1)	DK0806960T3 (sv)
ES (1)	ES2188672T3 (sv)
FI (1)	FI117376B (sv)
HU (1)	HU222088B1 (sv)
IS (1)	IS1963B (sv)
MX (1)	MX9705894A (sv)
NO (1)	NO318950B1 (sv)
NZ (1)	NZ294553A (sv)
PL (1)	PL188137B1 (sv)
RO (1)	RO117590B1 (sv)
RU (1)	RU2157695C2 (sv)
WO (1)	WO1996023512A1 (sv)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6380366B1 (en)	1994-04-28	2002-04-30	Les Laboratoires Aeterna Inc.	Shark cartilage extract:process of making, methods of using and compositions thereof
US6025334A (en) *	1994-04-28	2000-02-15	Les Laboratoires Aeterna Inc.	Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
AU724654B2 (en) *	1995-04-21	2000-09-28	Aeterna Zentaris Inc.	Extracts of shark cartilage
AU6639898A (en)	1997-02-20	1998-09-09	Industrial Research Limited	Angiogenesis inhibitors and activators from shark cartilage
ES2200316T3 (es) *	1997-03-11	2004-03-01	Les Laboratoires Aeterna Inc.	Composiciones para tratar tumores que contienen extractos de cartilago de tiburon y agentes antineoplasticos.
CN1288165C (zh) *	1997-07-11	2006-12-06	Cv技术公司	用于治疗与phf过多或细胞内钙过多相关疾病的来自鲨软骨的制剂
AUPO920597A0 (en) *	1997-09-16	1997-10-09	Micronized Foods Pty Ltd	Pharmaceutical and/or therapeutic composition or preparation comprising shark cartilage and emu oil
US20020009501A1 (en) *	1998-07-23	2002-01-24	Eric Dupont	Preparation of cartilage extracts using organic solvents
US6168807B1 (en)	1998-07-23	2001-01-02	Les Laboratoires Aeterna Inc.	Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof
CN1064690C (zh) *	1998-09-10	2001-04-18	中国人民解放军海军医学研究所	鲨鱼软骨血管生成抑制因子及其分离纯化方法
RU2161002C1 (ru) *	1999-07-30	2000-12-27	Государственное унитарное предприятие Тихоокеанский научно-исследовательский рыбохозяйственный центр	Пищевой общеукрепляющий лечебно-профилактический продукт из хрящевой ткани акул и способ его получения
US6248341B1 (en) *	2000-01-14	2001-06-19	Color Access, Inc.	Method of treating topical angiogenesis-related disorders
ATE536858T1 (de)	2000-04-18	2011-12-15	Medestea Int Spa	Zubereitung auf basis natürlicher extrakte zur vorbeugung und behandlung von hautfalten
AU1649802A (en) *	2000-12-20	2002-07-01	Ind Res Ltd	Shark meat extract
JPWO2004083257A1 (ja) *	2003-03-20	2006-06-22	ホソカワミクロン株式会社	軟骨魚類から単離されたプロテオグリカンおよびその製造方法
ES2223291B1 (es) *	2003-08-06	2006-03-16	Bioiberica, S.A.	Nuevo uso terapeutico de condroitin sulfato.
US7205006B2 (en) *	2003-09-25	2007-04-17	Prime Pharmaceutical Corporation	Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
CN100377741C (zh) *	2004-02-23	2008-04-02	江卫世	注射用复方骨肽及其制备工艺
RU2250774C1 (ru) *	2004-04-29	2005-04-27	Научно-исследовательский институт медико-биологических проблем Владикавказского научного центра РАН и Правительства РСО-Алания (НИИ МБП ВНЦ РАН)	Способ оптимизации лечения хронического простатита
US20070248930A1 (en)	2005-02-17	2007-10-25	Biolux Research Ltd.	Light therapy apparatus and methods
WO2012075584A1 (en)	2010-12-08	2012-06-14	Biolux Research Limited	Methods and apparatuses useful for regulating bone remodeling or tooth movement using light therapy, a functional appliance, and/or vitamin d
BR112014013561B1 (pt) *	2011-12-04	2019-04-24	David L. Liu	Composição farmacêutica útil para o tratamento de um câncer, tumor maligno, tumor benigno e doenças não-malignas
RU2489906C1 (ru) *	2012-04-18	2013-08-20	Тамара Ивановна Николаева	Биологически активная добавка к пище на основе денатурированного коллагена
US20130287859A1 (en) *	2012-04-26	2013-10-31	Lescarden Inc.	Method for treating prupritus with cartilage extract
DE102012023927A1 (de) *	2012-12-06	2014-06-12	Heinrich Huber	Heilsalbe gegen Psoriasis, auch als Wundsalbe verwendbar; 50 ml ohne Konservierung
CN105682603A (zh)	2013-10-22	2016-06-15	碧奥鲁克斯研究有限公司	口腔内光疗法装置以及使用它们的方法
CN106492065A (zh) *	2016-10-20	2017-03-15	王凯茜	一种治疗风湿热的中药
KR102369902B1 (ko) *	2021-04-23	2022-03-02	이수한	전 처리된 캐비아가 함유된 철갑상어 진액 및 그 제조 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4822607A (en) *	1976-10-29	1989-04-18	Lescarden Ltd.	Anti-tumor agent and method
US4473551A (en) *	1982-08-23	1984-09-25	Faxon Pharmaceuticals, Inc.	Anti-inflammatory composition
US4486414A (en) *	1983-03-21	1984-12-04	Arizona Board Of Reagents	Dolastatins A and B cell growth inhibitory substances
US5075112A (en) *	1990-02-12	1991-12-24	Cartilage Technologies Inc.	Method of and dosage unit for inhibiting angiogenesis or vascularization in an animal using shark cartilage
IT1244879B (it) *	1990-12-11	1994-09-12	Alberto Bartorelli	Estratti da tessuti animali, utili in terapia e in diagnostica.
RU2019180C1 (ru) *	1993-01-12	1994-09-15	Яков Давидович Безман	Средство для лечения подкожной фибросаркомы и способ его получения
RU2019173C1 (ru) *	1993-01-12	1994-09-15	Яков Давидович Безман	Способ лечения подкожной фибросаркомы
US5618925A (en) *	1994-04-28	1997-04-08	Les Laboratories Aeterna Inc.	Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof

1995
- 1995-10-30 AU AU37388/95A patent/AU717978B2/en not_active Ceased
- 1995-10-30 EP EP95935309A patent/EP0806960B1/en not_active Expired - Lifetime
- 1995-10-30 JP JP8523128A patent/JPH11502514A/ja active Pending
- 1995-10-30 CA CA002212010A patent/CA2212010C/en not_active Expired - Fee Related
- 1995-10-30 NZ NZ294553A patent/NZ294553A/xx unknown
- 1995-10-30 WO PCT/CA1995/000617 patent/WO1996023512A1/en not_active Ceased
- 1995-10-30 HU HU9800065A patent/HU222088B1/hu not_active IP Right Cessation
- 1995-10-30 ES ES95935309T patent/ES2188672T3/es not_active Expired - Lifetime
- 1995-10-30 RO RO97-01452A patent/RO117590B1/ro unknown
- 1995-10-30 PL PL95321678A patent/PL188137B1/pl not_active IP Right Cessation
- 1995-10-30 CN CNB951977598A patent/CN1138550C/zh not_active Expired - Fee Related
- 1995-10-30 AT AT95935309T patent/ATE230272T1/de not_active IP Right Cessation
- 1995-10-30 CZ CZ19972452A patent/CZ292627B6/cs not_active IP Right Cessation
- 1995-10-30 DE DE69529300T patent/DE69529300T2/de not_active Expired - Fee Related
- 1995-10-30 DK DK95935309T patent/DK0806960T3/da active
- 1995-10-30 RU RU97114752/14A patent/RU2157695C2/ru not_active IP Right Cessation
- 1995-10-30 KR KR1019970705335A patent/KR100347880B1/ko not_active Expired - Fee Related
- 1995-10-30 BR BR9510540A patent/BR9510540A/pt not_active Application Discontinuation
1997
- 1997-08-01 MX MX9705894A patent/MX9705894A/es not_active IP Right Cessation
- 1997-08-01 IS IS4537A patent/IS1963B/is unknown
- 1997-08-01 NO NO19973564A patent/NO318950B1/no unknown
- 1997-08-01 FI FI973195A patent/FI117376B/sv not_active IP Right Cessation
- 1997-09-01 BG BG101870A patent/BG63801B1/bg unknown
2003
- 2003-02-05 JP JP2003028771A patent/JP2003246742A/ja active Pending
2006
- 2006-07-31 JP JP2006208897A patent/JP2006290904A/ja active Pending

Also Published As

Publication number	Publication date
CN1177927A (zh)	1998-04-01
IS1963B (is)	2004-12-15
PL188137B1 (pl)	2004-12-31
CA2212010C (en)	2004-08-17
BR9510540A (pt)	1998-06-09
EP0806960B1 (en)	2003-01-02
FI973195A0 (sv)	1997-08-01
AU717978B2 (en)	2000-04-06
HU222088B1 (hu)	2003-04-28
BG101870A (en)	1998-04-30
JPH11502514A (ja)	1999-03-02
DE69529300D1 (de)	2003-02-06
DK0806960T3 (da)	2003-04-22
IS4537A (is)	1997-08-01
RU2157695C2 (ru)	2000-10-20
CN1138550C (zh)	2004-02-18
PL321678A1 (en)	1997-12-22
AU3738895A (en)	1996-08-21
EP0806960A1 (en)	1997-11-19
MX9705894A (es)	1998-07-31
CA2212010A1 (en)	1996-08-08
KR100347880B1 (ko)	2002-12-02
ES2188672T3 (es)	2003-07-01
WO1996023512A1 (en)	1996-08-08
DE69529300T2 (de)	2003-07-03
BG63801B1 (bg)	2003-01-31
ATE230272T1 (de)	2003-01-15
CZ245297A3 (cs)	1998-01-14
HUT77488A (hu)	1998-05-28
RO117590B1 (ro)	2002-05-30
NO973564L (no)	1997-10-01
NO973564D0 (no)	1997-08-01
CZ292627B6 (cs)	2003-11-12
FI117376B (sv)	2006-09-29
JP2003246742A (ja)	2003-09-02
NO318950B1 (no)	2005-05-30
NZ294553A (en)	1999-07-29
JP2006290904A (ja)	2006-10-26

Publication	Publication Date	Title
FI973195L (sv)	1997-10-01	Hajbroskextrakt, förfarande för framställning av desamma och deras användning
FI962917A7 (sv)	1996-07-19	Mikrokapslar, förfarande för deras framställning, och deras användning
EE9700074A (et)	1997-10-15	Antineoplastilised kakaoekstraktid, meetodid nende valmistamiseks ja nende ksutamine
FI951468L (sv)	1995-10-01	Lipopeptidderivat, förfarande för framställning och användning av desamma
EE9900147A (et)	1999-12-15	Oksadiasoolid, nende saamismeetodid ja kasutamine ravimitena
FI962927A7 (sv)	1996-07-19	Tetracyklinderivat, framställningsförfarande och användning
FI972164L (sv)	1997-07-21	Aerogelhaltigt kompositmaterial, förfarande för framställning därav och dess användning
FI972165A7 (sv)	1997-07-21	Aerogelhaltigt kompositmaterial, förfarande för framställning därav oc h dess användning
FI955235L (sv)	1996-05-03	Oxazolidindionderivat, deras framställning och användning
FI952679L (sv)	1995-12-04	Nya blandningar, förfarande för deras framställning och deras användning vid beläggningar
FI961457L (sv)	1997-09-30	Ny komplexförening, dess framställning och användning
EE03482B1 (et)	2001-08-15	Kinasoliiniderivaadid, nende valmistamismeetod ja kasutamine
DK0729956T3 (da)	2001-11-26	Benzothi9phenforbindelser, emllemprodukter, præparater og fremgangsmåder
EE03778B1 (et)	2002-06-17	Vähivaktsiin ja selle valmistamismeetod
FI951817L (sv)	1995-10-16	Organolluminoxyprodukt, dess framställning och användning
FI963646A7 (sv)	1996-09-16	Förgrenade polyoxa-alkylmakromolekyler, förfarande för framställning a v dessa och deras användningar
FI972264L (sv)	1998-11-28	Betainprodukt, förfarande för dess framställning, och dess användning
FI931232L (sv)	1994-09-20	Sötningsmedel, förfarande för dess framställning och användning av detsamma
FI972988L (sv)	1997-09-11	Förfarande och farmaceutiska kompositioner, i vilka desmetylselegilin används
ATE253641T1 (de)	2003-11-15	Antigenische präparationen
EE9800333A (et)	1999-04-15	Uued furaandiarüülmetülideeni derivaadid, nende valmistamise meetod ja kasutamine teraapias
FI953391L (sv)	1996-01-13	Kompositmaterial, förfarande för dess framställning och användning därav
FI972965L (sv)	1997-07-11	Nya peptider, deras framställning och användning
BR9600779A (pt)	1997-12-23	Benzenossulfoniluréias e -tioréias substituidas processo para sua preparação uso e medicamento
FI964446L (sv)	1997-01-03	Nya tetrapeptider, deras framställning och användning

Legal Events

Date	Code	Title	Description
2006-09-29	FG	Patent granted	Ref document number: 117376 Country of ref document: FI
2008-04-30	MA	Patent expired

Date

Code

Title

Description

2006-09-29

Patent granted

Ref document number: 117376

Country of ref document: FI

2008-04-30

Patent expired